You are here

  • Home
  • Archive
  • Volume 11, Issue 9
  • Correction: Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development

https://doi.org/10.1136/jitc-2023-007309corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Kluger HM, Tawbi H, Feltquate D, et al. Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development. J ImmunoTher Cancer 2023;11:e007309. doi: 10.1136/jitc-2023-007309.

    This article has been corrected since it was first published online. The author order was incorrect and has now been updated to the following: Hussein A Tawbi, Ryan J Sullivan, David Feltquate, Naiyer A Rizvi, Elad Sharon, Jeffrey Sosman, Harriet M Kluger. HAT and RJS contributed equally.